Looking At AbbVie's Recent Unusual Options Activity
Looking At AbbVie's Recent Unusual Options Activity
High-rolling investors have positioned themselves bearish on AbbVie (NYSE:ABBV), and it's important for retail traders to take note.\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in ABBV often signals that someone has privileged information.
赌徒投资者看淡了艾伯维公司（纽交所：ABBV），零售交易者要注意。我们通过Benzinga跟踪的公开期权数据，今天注意到了这种活动。这些投资者的身份不确定，但ABBV的如此重大变化通常意味着有人拥有特权信息。
Today, Benzinga's options scanner spotted 8 options trades for AbbVie. This is not a typical pattern.
今天，Benzinga的期权扫描器发现了8个艾伯维的期权交易，这不是一个典型的模式。
The sentiment among these major traders is split, with 25% bullish and 62% bearish. Among all the options we identified, there was one put, amounting to $32,558, and 7 calls, totaling $350,955.
这些主要交易商的情绪分裂，看涨25％，看跌62％。我们确定的所有期权中，有一个看跌期权，金额为32558美元，7个看涨期权，总额为350955美元。
Projected Price Targets
预计价格目标
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $140.0 to $180.0 for AbbVie during the past quarter.
分析这些合同的成交量和未平仓量，似乎大户已经关注了艾伯维公司在过去一个季度期间价格窗口从140.0美元到180.0美元的区间。
Volume & Open Interest Development
成交量和持仓量的评估是期权交易中的一个关键步骤。这些指标揭示了阿里巴巴集团（Alibaba Gr Hldgs）特定执行价格期权的流动性和投资者兴趣。下面的数据可视化了在过去30天内，阿里巴巴集团（Alibaba Gr Hldgs）在执行价格在74.0美元到120.0美元区间内的看涨看跌期权中，成交量和持仓量的波动情况。
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for AbbVie's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across AbbVie's significant trades, within a strike price range of $140.0 to $180.0, over the past month.
检查成交量和未平仓量提供了关键的股票研究见解。这些信息对于评估特定斗价的艾伯维公司期权的流动性和利益水平非常重要。在下面，我们提供了过去一个月内涉及艾伯维公司的重要交易中，在140.0美元至180.0美元的行情区间内，看跌期权和看涨期权的成交量和未平仓量趋势的快照。
AbbVie 30-Day Option Volume & Interest Snapshot
艾伯维公司30天期权成交量和持仓量快照
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | SWEEP | BEARISH | 07/19/24 | $9.65 | $9.0 | $9.08 | $160.00 | $118.1K | 1.3K | 0 |
| ABBV | CALL | TRADE | BEARISH | 03/21/25 | $12.9 | $12.65 | $12.65 | $170.00 | $59.4K | 203 | 3 |
| ABBV | CALL | SWEEP | BULLISH | 09/20/24 | $4.1 | $4.1 | $4.1 | $175.00 | $41.4K | 3.1K | 1 |
| ABBV | CALL | TRADE | NEUTRAL | 03/21/25 | $13.2 | $11.85 | $12.5 | $170.00 | $41.2K | 203 | 57 |
| ABBV | PUT | SWEEP | BEARISH | 07/19/24 | $1.46 | $1.44 | $1.45 | $165.00 | $32.5K | 4.0K | 20 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 艾伯维公司 | 看涨 | SWEEP | 看淡 | 07/19/24 | $9.65 | 9.0美元 | $9.08 | $160.00 | $118.1K | 1.3K | 0 |
| 艾伯维公司 | 看涨 | 交易 | 看淡 | 03/21/25 | $12.9 | $12.65 | $12.65 | $170.00 | $59.4K | 203 | 3 |
| 艾伯维公司 | 看涨 | SWEEP | 看好 | 09/20/24 | $4.1 | $4.1 | $4.1 | $175.00 | $41.4K | 3.1K | 1 |
| 艾伯维公司 | 看涨 | 交易 | 中立 | 03/21/25 | $13.2 | 11.85美元 | $12.5 | $170.00 | $41.2K | 203 | 57 |
| 艾伯维公司 | 看跌 | SWEEP | 看淡 | 07/19/24 | $1.46 | $1.44 | $1.45 | 165.00美元 | $32.5K | 4.0K | 20 |
About AbbVie
关于艾伯维公司
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie是一家药品公司，其在免疫学（包括Humira、Skyrizi和Rinvoq）和肿瘤学（包括Imbruvica和Venclexta）方面拥有强大的业务。该公司于2013年初从Abbott分拆而来。2020年收购雅培使其在美容业务（包括Botox）中新增了一些产品和药品。
After a thorough review of the options trading surrounding AbbVie, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
经过对艾伯维周边期权交易的详细审查，我们进一步审查公司的细节，包括对其当前市场状态和表现的评估。
Where Is AbbVie Standing Right Now?
艾伯维目前处于什么状态？
- Currently trading with a volume of 1,080,843, the ABBV's price is down by -1.3%, now at $168.93.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 28 days.
- 目前成交量为1,080,843，ABBV的价格下跌了-1.3％，现在为168.93美元。
- RSI读数表明该股目前可能接近超买水平。
- 预期财报发布在28天后。
Expert Opinions on AbbVie
关于艾伯维公司的专家意见
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $191.66666666666666.
在过去一个月中，有3位行业分析师分享了他们对这只股票的见解，提出了一个平均目标价191.66666666666666美元。
- An analyst from Piper Sandler persists with their Overweight rating on AbbVie, maintaining a target price of $190.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $200.
- An analyst from HSBC has elevated its stance to Buy, setting a new price target at $185.
- 派杰投资（Piper Sandler）的分析师坚持其对AbbVie的超配评级，保持目标价为$190。
- 康泰纳菲（Cantor Fitzgerald）的一位分析师将其评级降级为超配，设定了一个$200的目标价。
- 摩根士丹利（HSBC）的一位分析师将其立场提高到买入，设定了一个新的目标价在$185。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期权与仅交易股票相比是一种更具风险的资产，但它们具有更高的利润潜力。认真的期权交易者通过每日学习，进出交易，跟随多个指标并密切关注市场来管理这种风险。